期刊文献+
共找到904篇文章
< 1 2 46 >
每页显示 20 50 100
Effect of Taoren Quyu Decoction on human endometrial cells and its anti-endometriosis activity in rats 被引量:7
1
作者 Hai-Zhi Liu Xiao-Xue Han +2 位作者 Jia Liu Feng-Cheng Zhu Rui-Man Li 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2017年第7期758-762,共5页
Objective: To study the effect of Taoren Quyu Decoction (TQD) on endometrial cells in patients with endometriosis (EMs) and EMs in rats. Methods: A total of 60 female Wistar rats were randomly divided into 4 groups, n... Objective: To study the effect of Taoren Quyu Decoction (TQD) on endometrial cells in patients with endometriosis (EMs) and EMs in rats. Methods: A total of 60 female Wistar rats were randomly divided into 4 groups, namely, normal group, model group, positive group and TQD group, each group having 15 rats. Except the normal group, EMs model was established in the other three groups by transplanting the rat autologous endometrium. After 4 weeks of intragastric administration, blood, eutopic and ectopic endometrial tissues of rats in each group were collected to detect the serum levels of estrogen (E2), cancer antigen 125 (CA125), endometrial antibody (EMA13), and expressions of microvessel density (MVD), vascular endothelial growth factor (VEGF) and angiopoietin (Ang-2). The volume of endometriosis cyst was determined simultaneously. For the in vitro culture of human endometrial cells, 4 groups, namely, normal group, model group, positive group and TQD group were used. The positive group and TQD group were treated with danazol and TQD respectively. Then 24 h after the treatment, the expressions of survivin and tumor suppressor gene (p53) of each group were detected. Results: The volumes of the endometriosis cysts in the positive group and the TQD group were significantly reduced compared with the model group (P<0.05). The serum levels of E2, CA125 and EMAb, and the expressions of MVD. VEGF and Ang-2 in the model group were significantly increased compared with the normal group (P<0.0.5): while they were all significantly reduced in the positive group and TQD group (P<0.05). Compared with the normal group, the expression of survivin in the model group was significantly up regulated (/1/40.05), and expression of p53 was significantly reduced (P<0.05); compared with the model group, the expressions of survivin in the positive and TQD groups were significantly decreased (P<0.05), and expression of p53 was significantly up-regulated (P<0.05). The difference between positive group and TQD group was not statistically significant (P>0.05). Conclusions: TQD has a significant anti-EMs effect, and its mechanism of action may be related to anti-angiogenesis and promoting apoptosis of ectopic endometrial cell. 展开更多
关键词 Taoren quyu Decoction ENDOMETRIOSIS Endometrial cell RATS ANGIOGENESIS Apoptosis
暂未订购
Network pharmacology-based exploration of molecular mechanisms underlying therapeutic effects of Jianpi Huatan Quyu recipe on chronic heart failure with spleen Qi deficiency syndrome 被引量:1
2
作者 Si-Qi Li Dong-Yu Min +7 位作者 Jun-Wen Jiang Xiao-Ying Li Xu-Na Yang Wen-Bo Gu Jia-Hui Jiang Li-Hao Chen Han Nan Ze-Yu Chen 《World Journal of Cardiology》 2024年第7期422-435,共14页
BACKGROUND Chronic heart failure is a complex clinical syndrome.The Chinese herbal compound preparation Jianpi Huatan Quyu recipe has been used to treat chronic heart failure;however,the underlying molecular mechanism... BACKGROUND Chronic heart failure is a complex clinical syndrome.The Chinese herbal compound preparation Jianpi Huatan Quyu recipe has been used to treat chronic heart failure;however,the underlying molecular mechanism is still not clear.AIM To identify the effective active ingredients of Jianpi Huatan Quyu recipe and explore its molecular mechanism in the treatment of chronic heart failure.METHODS The effective active ingredients of eight herbs composing Jianpi Huatan Quyu recipe were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform.The target genes of chronic heart failure were searched in the Genecards database.The target proteins of active ingredients were mapped to chronic heart failure target genes to obtain the common drugdisease targets,which were then used to construct a key chemical componenttarget network using Cytoscape 3.7.2 software.The protein-protein interaction network was constructed using the String database.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed through the Metascape database.Finally,our previously published relevant articles were searched to verify the results obtained via network pharmacology.RESULTS A total of 227 effective active ingredients for Jianpi Huatan Quyu recipe were identified,of which quercetin,kaempferol,7-methoxy-2-methyl isoflavone,formononetin,and isorhamnetin may be key active ingredients and involved in the therapeutic effects of TCM by acting on STAT3,MAPK3,AKT1,JUN,MAPK1,TP53,TNF,HSP90AA1,p65,MAPK8,MAPK14,IL6,EGFR,EDN1,FOS,and other proteins.The pathways identified by KEGG enrichment analysis include pathways in cancer,IL-17 signaling pathway,PI3K-Akt signaling pathway,HIF-1 signaling pathway,calcium signaling pathway,cAMP signaling pathway,NF-kappaB signaling pathway,AMPK signaling pathway,etc.Previous studies on Jianpi Huatan Quyu recipe suggested that this Chinese compound preparation can regulate the TNF-α,IL-6,MAPK,cAMP,and AMPK pathways to affect the mitochondrial structure of myocardial cells,oxidative stress,and energy metabolism,thus achieving the therapeutic effects on chronic heart failure.CONCLUSION The Chinese medicine compound preparation Jianpi Huatan Quyu recipe exerts therapeutic effects on chronic heart failure possibly by influencing the mitochondrial structure of cardiomyocytes,oxidative stress,energy metabolism,and other processes.Future studies are warranted to investigate the role of the IL-17 signaling pathway,PI3K-Akt signaling pathway,HIF-1 signaling pathway,and other pathways in mediating the therapeutic effects of Jianpi Huatan Quyu recipe on chronic heart failure. 展开更多
关键词 Jianpi Huatan quyu recipe Traditional Chinese medicine Chronic heart failure Data mining Network pharmacology BIOINFORMATICS Spleen Qi deficiency syndrome
暂未订购
Yiqi Yangyin and Huatan Quyu granule can improve skeletal muscle energy metabolism in a type 2 diabetic rat model by promoting the AMPK/SIRT/PGC-1α signalling pathway
3
作者 Wei Huang Jinna Liu +3 位作者 Jing Zhao Bangzhong Wang Biyuan Liu Ming Xie 《Journal of Traditional Chinese Medical Sciences》 2018年第2期128-138,共11页
Objective:To investigate how Yiqi Yangyin and Huatan Quyu granule (YYHO) improves skeletal muscle insulin resistance in a type 2 diabetic rat model and to discover whether the molecular mechanism is related to the pro... Objective:To investigate how Yiqi Yangyin and Huatan Quyu granule (YYHO) improves skeletal muscle insulin resistance in a type 2 diabetic rat model and to discover whether the molecular mechanism is related to the promotion of the AMPK/SIRT/PGC-1α signalling pathway.Methods:Rats were randomly divided into 4 groups:the normal group,the model group,the YYHQ granule group,and the pioglitazone group.The type 2 diabetic rat model was established by feeding a high-fat diet for 5 weeks along with a single intraperitoneal injection of 30 mg/kg streptozotocin (STZ).After modelling successfully,the appropriate drug was intragastrically administered to diabetic rats for 2 weeks,once per day.The YYHQ granule group was given a dose of 4.8 g/kg body weight per day,the pioglitazone group was given a dose of 1.35 mg/kg body weight per day.The doses for both groups were equivalent to the clinical equivalent dose based on a previous study.Other groups were gavaged with the same amount of saline water.Body weight,food intake,water intake,urine volume and grip strength were recorded weekly.The fasting blood glucose(FBG) was determined weekly using blood glucose test strips.The related glucose and lipid metabolism indexes,e.g.,fasting insulin (Fins),glycated haemoglobin (GHb),HOMA-IR,ISI,triglycerides (TG),total cholesterol (TC),high-density lipoprotein cholesterol (HDL-C),low-density lipoprotein cholesterol (LDL-C) and free fatty acid (FFA),were determined using biochemical method.The mRNA expression levels of adenosine monophosphate-activated protein kinase (AMPK),peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α),carnitine palmitoyl transterase-1 (CPT-1),Sirtuin 1 (SIRT1),and Sirtuin 3 (SIRT3) were assessed using quantitative real-time PCR (qRT-PCR).The protein expression levels of creatine kinase (CK),Ca2+ ATPase,α-Actin,AMPK,PGC-1α and CPT-1 were determined using enzyme-linked immunosorbent assay method (ELISA).Results:Body weight decreased significantly (P <.01),food intake,water intake and urine volume increased significantly (P <.01),and grip strength decreased significantly (P <.01) in the model group compared with the normal group.The levels of FBG,Fins,GHb and HOMA-IR increased significantly (P <.01),and the ISI decreased significantly (P <.01) in the model group.The levels of TG,TC,LDL-C and FFA increased significantly (P <.05 or P <.01),and the level of HDL-C decreased significantly (P <.05) in the model group.These changes were reversed after treatment with YYHQ granule or pioglitazone.Compared with the model group,the YYHQ granule and pioglitazone groups significantly improve body weight,water intake and urine volume (P <.05 or P <.01),however,both treatments had no significant effect on food intake (P >.05).The levels of FBG,Fins,GHb,HOMA-IR and ISI were improved significantly (P <.01) and the levels of TG,TC and LDL-C were improved significantly (P <.05 or P <.01),however,both treatments had no significant effect on the levels of HDL-C and FFA (P >.05).Further results indicated that YYHQ granule significantly decreased the mRNA expression of AMPK,PGC-1α,CPT-1,SIRT1 and SIRT3 in skeletal muscle (P <.01) and the pioglitazone group showed similar effects;moreover,the protein expression levels of CK,Ca2+ATPase,α-Actin,AMPK,PGC-1α and CPT-1 in skeletal muscle significantly decreased (P <.01),however,pioglitazone had no significant effect on CK and α-Actin (P >.05).Conclusion:The possible molecular mechanism of YYHQ granule improving skeletal muscle insulin resistance in a type 2 diabetic rat model may be related to the stimulation of energy metabolism in skeletal muscle via the AMPK/SIRT/PGC-1α signalling pathway. 展开更多
关键词 TYPE 2 diabetes mellitus (T2DM) Yiqi Yangyin and Huatan quyu GRANULE (YYHQ) Skeletal muscle Energy metabolism AMPK/SIRT/PGC-1α signalling pathway
暂未订购
Effect of Huatan Quyu Decoction on Stable Angina Pectoris Patients with Coronary Heart Disease of Phlegm and Blood Stasis Syndrome
4
作者 GONG Weiling 《外文科技期刊数据库(文摘版)医药卫生》 2021年第5期395-396,共3页
Experimental objective: to study the effect of Huatan Quyu Decoction on patients with stable angina pectoris of coronary heart disease with phlegm-blood stasis syndrome. Step: select 100 patients from the patients rec... Experimental objective: to study the effect of Huatan Quyu Decoction on patients with stable angina pectoris of coronary heart disease with phlegm-blood stasis syndrome. Step: select 100 patients from the patients received by the hospital in the past two years, and then randomly divide them into 2 groups with 50 patients in each group. Use different treatment methods to compare and study the differences between the two. The patients in the first group were treated with conventional methods, mainly isosorbide dinitrate, while the patients in the second group were treated with Huatan Quyu Decoction. The experiment is mainly to analyze the differences of the related physical indexes between the two groups of patients before and after treatment, and the main parameters include: cardiac function, degree of angina pectoris. Experimental results: There was no significant difference in physical indexes between the two groups before treatment, while the physical condition of the second group improved after treatment, while the physical condition of the first group did not improve significantly. Conclusion: Huatan Quyu Decoction has certain effect in treating stable angina pectoris of coronary heart disease, and has good effect in improving cardiac function of patients, which can be used clinically. 展开更多
关键词 Huatan quyu Decoction patients with stable angina pectoris of coronary heart disease due to phlegm
暂未订购
Expressions of VEGF and Ki-67 in Eutopic Endometrium of Patients with Endometriosis and Effect of Quyu Jiedu Recipe (祛瘀解毒方) on VEGF Expression 被引量:4
5
作者 连方 刘海萍 +6 位作者 王云霞 张建伟 孙振高 马凤梅 张宁 刘延荷 孟茜 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第2期109-114,共6页
Objective: To observe the clinical efficacy of Quyu Jiedu Recipe (祛瘀解毒方,QJR) in treating endometriosis (EM), and to explore the levels of vascular endothelial growth factor (VEGF) and cell proliferative nu... Objective: To observe the clinical efficacy of Quyu Jiedu Recipe (祛瘀解毒方,QJR) in treating endometriosis (EM), and to explore the levels of vascular endothelial growth factor (VEGF) and cell proliferative nucleoprotein antigen (Ki-67), their changes before and after treatment and the clinical significance in the trial. Methods: Fifty patients of EM were randomly assigned to two groups. The 26 patients in the Q JR group were treated with Q JR, and the 24 patients in the gestrinone (GT) group with gestrinone. Besides, a normal control group with 20 healthy women was set up. The therapeutic effects in the two treated groups were compared. Expressions of VEGF and Ki-67 in eutopic endometrium of all subjects (with both patients and healthy women at the median secretive phase) were determined with immunohistochemical stain before treatment, and the determination in the two treated groups was repeated after 3-month treatment in the same phase. Results: Before treatment, the VEGF and Ki-67 expression positive rates and their mean optic density (MOD) were higher in patients than in healthy women (P〈0.05). After treatment, the positive rate and MOD of VEGF expression lowered significantly than before treatment (P〈0.05), but those of Ki-67 changed insignificantly, and comparison between the two treated groups showed no significant difference (P〉0.05). Conclusion: Q JR could markedly improve the symptoms of menorrhagia and menstrual disorder, and its mechanism might be related with the lowering of eutopic endometrial VEGF expression. VEGF and Ki-67 show a high expression in eutopic endometrium of patients with EM. 展开更多
关键词 ENDOMETRIOSIS quyu Jiedu Recipe stagnancy of toxin vascular endothelial growth factor KI-67
原文传递
Effect of Quyu Jiedu Granule(祛瘀解毒颗粒) on Micro-environment of Ova in Patients with Endometriosis 被引量:3
6
作者 连方 李新玲 +3 位作者 孙振高 张建伟 刘延荷 马凤梅 《Chinese Journal of Integrative Medicine》 SCIE CAS 2009年第1期42-46,共5页
Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo tra... Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo transfer(IVF-ET) were randomized equally into a treated group and a control group. Further,20 patients who received IVF-ET due to oviduct factors were enrolled into a non-endometriosis group. The dosage of gonadotrophic hormone used,the number of ova attained,fertilization rate and clinical pregnancy ra... 展开更多
关键词 ENDOMETRIOSIS quyu Jiedu Granule in vitro fertilization follicular fluid granular cells tumor necrosis factorα interleukin 6
原文传递
Qingre Quyu Granule(清热祛瘀颗粒)Stabilizes Plaques through Inhibiting the Expression of Tenascin-C in Patients with Severe Carotid Stenosis 被引量:2
7
作者 王一 程文立 +6 位作者 王勇 彭婧嫔 袁杰 陈莉 潘琳 李鸿 郭健 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2015年第5期339-345,共7页
Objective: To investigate the therapeutic effects of Qingre Quyu Granule (请热祛瘀颗粒, QQG) on the patients with severe carotid stenosis, and to explore the mechanism of it. Methods: Ninety-six patients with seve... Objective: To investigate the therapeutic effects of Qingre Quyu Granule (请热祛瘀颗粒, QQG) on the patients with severe carotid stenosis, and to explore the mechanism of it. Methods: Ninety-six patients with severe carotid stenosis were enrolled in the study and were classified into a QQG group (n=48) and a control group (n=48) randomly using consecutively numbered envelopes. The patients in the QQG group were given QQG and Western medicine, those in the control group were given Western medicine merely, the course of treatment was 16 weeks. All patients went through endarterectomy after treatment. Plaques were subjected to the analysis of CD3, CD68, soluble intercellular adhesion molecule 1 (ICAM-1), matrix metalloprotease-9 (MMP-9), CD40L, tenascin-C, and collagen content lipid content by immunohistochemistry or polarized light analysis. Results: By the end of experiment, the expressions of CD3, CD68, ICAM-1, MMP9, CD40L and tenascin-C on the plaques were statistically significant lower in the QQG group compared with the control group (P〈0.01), The lipid content of the plaque was also significantly lower in the QQG group compared with the control group (P〈O.01), The interstitial collagen in the tissue sections of the plaques was also significantly higher in the QQG group in comparison with the control group (P〈0.01). Conclusion: QQG could stabilize carotid artery plaques through inhibiting pro-inflammation factors and restraining the tenascin-C and MMP9 pathway. 展开更多
关键词 vulnerable atherosclerotic plaque CD40L matrix metalloprotease-9 TENASCIN-C Chinesemedicine Qingre quyue Granule
原文传递
Effect of Quyu Chencuo Formula(去菀陈莝方)on Renal Fibrosis in Obstructive Nephropathy Rats 被引量:1
8
作者 ZHU Rui DU Xing-guo +2 位作者 YANG Sheng-lan WU Yan-ran LIU Jian-guo 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2019年第3期190-196,共7页
Objective: To observe the effect of Quyu Chencuo Formula(去菀陈莝方, QCF) on renal fibrosis in rats with obstructive nephropathy. Methods: Twenty-four rats were randomly divided into three groups, 4 for sham operation... Objective: To observe the effect of Quyu Chencuo Formula(去菀陈莝方, QCF) on renal fibrosis in rats with obstructive nephropathy. Methods: Twenty-four rats were randomly divided into three groups, 4 for sham operation as the control group, 10 for unilateral ureteral obstruction(UUO) model group, and the rest 10 for QCF treating UUO model group. All rats were sacrificed under 3% pentobarbital(50 mg/kg) anesthesia on the 14 th day after surgery, then the right kidney samples of rats were harvested for hematoxylin eosin(HE) staining and Masson staining to observe the renal pathological changes. Immunohistochemistry and Western blotting were used to examine the expression of transforming growth factor β1(TGF-β1), and real-time polymerase chain reaction(RT-PCR) was employed to examine the expressions of TGF-β1, α-smooth muscle actin(α-SMA) and E-cadherin mRNA. Results: HE and Masson staining showed that the renal interstitial of the rats in the control group had no significant fibrotic lesion; in the model group, there were obvious interstitial fibrosis; for the QCF group, there were epithelial cell necrosis, infiltration of lymphocytes and mononuclear cells, aggravated interstitial fibrosis in varied degrees, but the pathological changes were less in the QCF group than in the model group. The immunohistochemistry and Western blotting results showed that the TGF-β1 expression was increased significantly in the model group, while decreased significantly in the QCF group(P<0.05); RT-PCR showed that the mRNA expression of α-SMA and TGF-β1 increased significantly in the model group, while both were significantly decreased in the QCF group compared with the model group(P<0.05). The mRNA expression of E-cadherin was decreased significantly in the model group, and it was significantly increased in the QCF group as compared with the model group(P<0.05). Conclusion: QCF may improve renal fibrosis by regulating the expressions of TGF-β1, α-SMA and E-cadherin, and prevent the progress of kidney fibrosis. 展开更多
关键词 UNILATERAL ureteral LIGATION quyu Chencuo FORMULA E-cadherin transforming growth factor β 1 α-smooth muscle ACTIN kidney FIBROSIS Chinese medicine
原文传递
祛瘀生新方对溃疡性结肠炎患者肠道菌群多样性、肠黏膜屏障指标及中医证候积分的影响
9
作者 尹本翻 陈步强 +4 位作者 张旗林 梁彪 钱诗维 黄硕 王振宜 《广州中医药大学学报》 2026年第1期79-85,共7页
【目的】探究祛瘀生新方(由黄芪、太子参、白术、生地黄、鸡眼草、地锦草、桃仁、川芎等组成)对溃疡性结肠炎(UC)患者肠道菌群多样性、肠黏膜屏障指标及中医证候积分的影响。【方法】选取2022年11月至2024年10月在上海中医药大学附属第... 【目的】探究祛瘀生新方(由黄芪、太子参、白术、生地黄、鸡眼草、地锦草、桃仁、川芎等组成)对溃疡性结肠炎(UC)患者肠道菌群多样性、肠黏膜屏障指标及中医证候积分的影响。【方法】选取2022年11月至2024年10月在上海中医药大学附属第七人民医院就诊的脾胃气虚型UC患者100例,按照随机数字表法将患者随机分为常规组和祛瘀生新组,每组各50例。常规组给予美沙拉嗪肠溶片联合双歧杆菌乳杆菌三联活菌片的西医常规治疗,祛瘀生新组在常规组的基础上联合祛瘀生新方治疗。2组均以1个月为1个疗程,连续治疗3个疗程。观察2组患者治疗前后肠道菌群多样性、肠黏膜屏障指标、中医证候积分的变化情况,并评价2组患者的临床疗效。【结果】(1)临床疗效方面,治疗3个月后,祛瘀生新组的总有效率为96.00%(48/50),常规组为82.00%(41/50),组间比较(χ^(2)检验),祛瘀生新组的疗效明显优于常规组(P<0.05)。(2)肠道菌群多样性方面,治疗后,2组患者的双歧杆菌、乳酸杆菌均较治疗前明显增多(P<0.01),肠球菌、肠杆菌均较治疗前明显减少(P<0.01),且祛瘀生新组对双歧杆菌、乳酸杆菌的增多程度及对肠球菌、肠杆菌的减少程度均明显优于常规组(P<0.05)。(3)肠黏膜屏障指标方面,治疗后,2组患者的血清二胺氧化酶(DAO)、D-乳酸、内毒素(ET)水平均较治疗前下降(P<0.01),且祛瘀生新组的下降幅度均明显优于常规组(P<0.05)。(4)中医证候积分方面,治疗后,2组患者的腹痛、腹泻、黏液血便、食少纳差等中医证候积分均较治疗前明显下降(P<0.01),且祛瘀生新组的下降幅度均明显优于常规组(P<0.05)。【结论】祛瘀生新方在脾胃气虚型UC患者的治疗中临床疗效突出,能明显缓解黏液血便、腹痛等症状,显著降低中医证候积分;能显著提升患者肠道菌群多样性,促进双歧杆菌、乳酸杆菌等益生菌增殖,抑制致病菌生长,优化肠道微生态环境,修复受损肠黏膜屏障,增强肠道防御功能。研究结果体现了祛瘀生新方在调节UC患者的肠道菌群、修复肠黏膜及改善临床症状方面的综合优势。 展开更多
关键词 祛瘀生新方 溃疡性结肠炎 脾胃气虚型 肠道菌群多样性 肠黏膜屏障指标 中医证候积分
原文传递
基于ACSL4/SLC7A11/GPX4通路探讨解毒祛瘀滋阴方抑制铁死亡治疗狼疮性肾炎的作用机制
10
作者 陈华玲 金吴萌 +1 位作者 胡长锋 卢璐 《浙江中医药大学学报》 2026年第1期1-15,共15页
[目的]探讨解毒祛瘀滋阴方通过抑制肾脏铁死亡治疗狼疮性肾炎(lupus nephritis,LN)的作用机制。[方法]18只雌性MRL/lpr狼疮小鼠随机分为模型组、激素组(5 mg·kg^(-1))和解毒祛瘀滋阴方组(18.2 g·kg^(-1));6只MRL/MpJ小鼠作为... [目的]探讨解毒祛瘀滋阴方通过抑制肾脏铁死亡治疗狼疮性肾炎(lupus nephritis,LN)的作用机制。[方法]18只雌性MRL/lpr狼疮小鼠随机分为模型组、激素组(5 mg·kg^(-1))和解毒祛瘀滋阴方组(18.2 g·kg^(-1));6只MRL/MpJ小鼠作为正常组,连续干预8周。干预结束后,计算各组小鼠脾脏和淋巴结指数;检测血清BUN、Cr、尿微量白蛋白(urine albumin,U-ALB)以及尿总蛋白(urine total protein,UTP)水平;ELISA法检测抗双链DNA(double-stranded DNA,dsDNA)抗体、抗核抗体(anti-nuclear antibody,ANA)、IL-17A、IL-6、IL-10水平;HE染色、免疫组化和免疫荧光法观察肾脏病理形态学变化;透射电镜观察肾脏皮质和髓质的线粒体超微结构;免疫印迹法和RT-qPCR分别检测小鼠肾脏中长链酰基辅酶A合成酶4(long-chain acyl-CoA synthetase 4,ACSL4)、溶质载体家族7成员11(solute carrier family 7 members 11,SLC7A11)、谷胱甘肽过氧化物酶4(glutathione peroxidase 4,GPX4)蛋白及mRNA的表达。以肾小管上皮细胞(renal tubular epithelial cells,RTECs)为研究对象,均加入脂质活性氧生成剂叔丁基过氧化氢(tert-butyl hydroperoxide,TBHP),来源于MRL/lpr小鼠的RTECs加入解毒祛瘀滋阴方含药血清和甲泼尼龙悬液进行干预,检测各组细胞内脂质过氧化、活性氧(reactive oxygen species,ROS)和Fe^(2+)水平,免疫印迹法检测皮质RTECs的铁死亡相关蛋白水平。[结果]与模型组比较,各治疗组小鼠脾脏和淋巴结肿大显著缓解(P<0.05,P<0.01);血清BUN、Cr、抗dsDNA抗体、ANA、IL-17A、IL-6、IL-10、U-ALB、UTP水平显著降低(P<0.05,P<0.01);肾脏线粒体损伤明显减轻、炎症细胞浸润减少,补体C3和IgG沉积明显减少(P<0.01)。解毒祛瘀滋阴方治疗后肾脏ACSL4蛋白及mRNA表达均下降,SLC7A11蛋白及mRNA和GPX4 mRNA表达均升高(P<0.05,P<0.01)。体外实验提示,MRL/lpr小鼠肾皮质RTECs的脂质过氧化、ROS水平和Fe^(2+)水平显著高于正常小鼠(P<0.05,P<0.01),TBHP处理后差异更加明显(P<0.05,P<0.01)。解毒祛瘀滋阴方能够降低细胞内脂质过氧化和ROS水平,减少铁积累,抑制ACSL4的表达,增加SLC7A11和GPX4的表达(P<0.05,P<0.01)。[结论]解毒祛瘀滋阴方通过调控ACSL4/SLC7A11/GPX4通路干预铁死亡,减轻肾脏RTECs的氧化损伤,提高抗氧化能力,从而缓解LN的肾脏损害。 展开更多
关键词 狼疮性肾炎 解毒祛瘀滋阴方 铁死亡 肾小管上皮细胞 线粒体 ACSL4/SLC7A11/GPX4 肾皮质 肾髓质
暂未订购
Effects of Quyu Xiaoban Capsule (祛瘀消斑胶囊) on Vascular Endothelial Function in Patients with Atherosclerosis
11
作者 刘运芳 赵玉霞 于会明 《Chinese Journal of Integrative Medicine》 SCIE CAS 2006年第3期171-174,共4页
Objective: To evaluate the therapeutic effects of Quyu Xiaoban Capsule (祛瘀消斑胶带), QYXBC) on endothelial dependent vascular relaxation (EDVR) function in patients with atherosclerosis (AS) with ultrasonic ... Objective: To evaluate the therapeutic effects of Quyu Xiaoban Capsule (祛瘀消斑胶带), QYXBC) on endothelial dependent vascular relaxation (EDVR) function in patients with atherosclerosis (AS) with ultrasonic technique. Methods: Tested were the endothelial function and blood lipids of 42 patients with AS in the treated group and 30 healthy volunteers in the control group. And re-examination of these parameters was carried out on the AS patients after they had been treated with QYXBC for 10 months. Results: Before treatment, the reactive hyperemia induced changes in artery diameter in the treated group was significantly lower than that in the control group (P〈0.01), while insignificant difference was found between the two groups in response to nitroglycerin. In the treated group after treatment, with D%-R improved significantly (P〈0.01), total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) decreased by 16.3%, 5.6%, 10.2% respectively and high-density lipoprotein cholesterol (HDL-C) increased by 7.5%. EDVR was correlated negatively with the serum TC, LDL-C concentrations and the baseline brachial diameter (D0) (r = -0.41, -0.66, -0.59, respectively, all P〈0.01), but correlated positively with HDL-C (r=0.62, P〈0.05). The ameliorative extent of EDVR was correlated positively to the decreased magnitude of TC and LDL-C concentrations (r = 0.67,0.59, both P〈0.01). Conclusion: QYXBC can lower the level of blood lipids and improve significantly EDVR function. 展开更多
关键词 quyu Xiaoban Capsule ATHEROSCLEROSIS endothelial function
原文传递
益肾健脾祛瘀方联合常规西药治疗糖尿病肾病脾肾气虚证患者的效果
12
作者 李本斐 《中国民康医学》 2026年第3期120-123,共4页
目的:观察益肾健脾祛瘀方联合常规西药治疗糖尿病肾病(DN)脾肾气虚证患者的效果。方法:选取2022年5月至2024年5月该院收治的92例DN脾肾气虚证患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各46例。对照组给予常规西药治疗... 目的:观察益肾健脾祛瘀方联合常规西药治疗糖尿病肾病(DN)脾肾气虚证患者的效果。方法:选取2022年5月至2024年5月该院收治的92例DN脾肾气虚证患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各46例。对照组给予常规西药治疗,观察组在对照组基础上联合益肾健脾祛瘀方治疗。比较两组临床疗效,治疗前后中医证候积分、肾功能指标[血肌酐(Scr)、血尿素氮(BUN)、肾小球滤过率(GFR)、24 h尿蛋白定量(24hUP)]水平,以及不良反应发生率。结果:观察组治疗总有效率为95.65%,高于对照组的80.43%,差异有统计学意义(P<0.05);治疗后,两组面色萎黄、神疲乏力、食欲不振、腰膝酸软等中医证候积分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后,两组GFR水平均高于治疗前,且观察组高于对照组,两组Scr、BUN、24hUP水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:益肾健脾祛瘀方治疗DN脾肾气虚证患者,可提高临床疗效,降低中医证候积分,改善肾功能,效果优于常规西药治疗。 展开更多
关键词 糖尿病肾病 脾肾气虚证 益肾健脾祛瘀方 肾功能 中医证候积分 不良反应
暂未订购
益气养阴祛瘀方联合西药治疗糖尿病肾病Ⅲ~Ⅳ期合并动脉粥样硬化气阴两虚夹瘀证临床研究
13
作者 吴晓芸 陈美雪 +1 位作者 张春灵 万鸣宏 《新中医》 2026年第2期21-27,共7页
目的:观察益气养阴祛瘀方联合西药治疗糖尿病肾病(DKD)Ⅲ~Ⅳ期合并动脉粥样硬化(AS)气阴两虚夹瘀证的临床疗效以及对患者脂质代谢的影响。方法:选取2023年4月—2024年3月嘉兴大学附属平湖市中医医院肾病科收治的80例DKDⅢ~Ⅳ期合并AS气... 目的:观察益气养阴祛瘀方联合西药治疗糖尿病肾病(DKD)Ⅲ~Ⅳ期合并动脉粥样硬化(AS)气阴两虚夹瘀证的临床疗效以及对患者脂质代谢的影响。方法:选取2023年4月—2024年3月嘉兴大学附属平湖市中医医院肾病科收治的80例DKDⅢ~Ⅳ期合并AS气阴两虚夹瘀证患者,依据随机数字表法分为观察组和对照组,每组40例。研究期间,观察组脱落2例、剔除3例,对照组脱落1例、剔除2例。对照组给予西药治疗,观察组在对照组基础上加用益气养阴祛瘀方。2组均治疗24周。评估2组中医证候疗效及安全性,比较2组AS相关指标[颈动脉内膜中层厚度(IMT)、斑块面积]、中医证候积分、血脂指标[甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)]、肾功能指标[血肌酐(SCr)、估算肾小球滤过率(eGFR)、24 h尿蛋白定量)]及血糖指标[空腹血糖(FBG)、餐后2 h血糖(P2hBG)、糖化血红蛋白(HbA1c)]。结果:观察组中医证候疗效总有效率94.29%(33/35),高于对照组29.73%(11/37)(P<0.05)。治疗后,2组IMT均较治疗前变薄(P<0.05),斑块面积均较治疗前缩小(P<0.05);观察组IMT薄于对照组(P<0.05),斑块面积小于对照组(P<0.05)。治疗后,2组中医证候积分均较治疗前降低(P<0.05),观察组中医证候积分低于对照组(P<0.05)。治疗后,2组TG、TC、LDL-C、SCr、24 h尿蛋白定量、FBG、P2hBG、HbA1c水平均较治疗前降低(P<0.05),HDL-C、eGFR水平均较治疗前升高(P<0.05);观察组TG、TC、LDL-C、SCr、24 h尿蛋白定量、FBG、P2hBG、HbA1c水平均低于对照组(P<0.05),HDL-C、eGFR水平均高于对照组(P<0.05)。2组均未见严重不良反应。结论:益气养阴祛瘀方联合西药能安全有效地治疗DKDⅢ~Ⅳ期合并AS气阴两虚夹瘀证,调节脂质代谢紊乱,缩小斑块面积,有助于改善肾功能,进而延缓病情进展。 展开更多
关键词 糖尿病肾病 动脉粥样硬化 气阴两虚夹瘀证 益气养阴祛瘀方 肾功能 脂质代谢
原文传递
祛瘀生肌方治疗慢性糖尿病性溃疡瘀证的临床研究
14
作者 李苏 郭婉军 +5 位作者 丁晓杰 陈佳乐 蒯仂 李欣 李福伦 迮侃 《中华中医药杂志》 北大核心 2025年第7期3941-3945,共5页
目的:明确祛瘀生肌方临床治疗慢性糖尿病性溃疡瘀证的有效性和安全性。方法:采用随机、对照研究方法,以慢性糖尿病性溃疡瘀证患者为研究对象,经4周祛瘀生肌方治疗后,比较治疗前后创面面积、愈合速度、症状积分、面积疗效、症状积分疗效... 目的:明确祛瘀生肌方临床治疗慢性糖尿病性溃疡瘀证的有效性和安全性。方法:采用随机、对照研究方法,以慢性糖尿病性溃疡瘀证患者为研究对象,经4周祛瘀生肌方治疗后,比较治疗前后创面面积、愈合速度、症状积分、面积疗效、症状积分疗效和安全性。结果:对照组创面面积疗效总有效率为40.00%(12/30),治疗组总有效率为80.65%(25/31),治疗组显著高于对照组(P<0.01)。结论:祛瘀生肌方能促进慢性糖尿病性溃疡瘀证患者创面愈合,改善创面症状积分。 展开更多
关键词 祛瘀生肌方 糖尿病 慢性糖尿病性溃疡 皮肤溃疡 瘀证 临床研究
原文传递
固本祛瘀解毒方治疗慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停低通气综合征夜间低氧血症的临床观察
15
作者 何沂 李紫雨 +3 位作者 张文江 高金柱 樊长征 王蓓蓓 《中国实验方剂学杂志》 北大核心 2025年第6期146-153,共8页
目的:观察固本祛瘀解毒方治疗慢性阻塞性肺疾病(COPD)合并阻塞性睡眠呼吸暂停低通气综合征(OSAHS)夜间低氧血症(肺脾肾虚、瘀毒交阻证)的临床疗效及安全性。方法:采用前瞻性、随机双盲、安慰剂对照的设计方法,选择符合COPD合并OSAHS的... 目的:观察固本祛瘀解毒方治疗慢性阻塞性肺疾病(COPD)合并阻塞性睡眠呼吸暂停低通气综合征(OSAHS)夜间低氧血症(肺脾肾虚、瘀毒交阻证)的临床疗效及安全性。方法:采用前瞻性、随机双盲、安慰剂对照的设计方法,选择符合COPD合并OSAHS的西医诊断标准且中医辨证为肺脾肾虚、瘀毒交阻证患者96例,随机分为观察组和对照组,各48例。两组均在西医常规治疗基础上,观察组加用固本祛瘀解毒方,对照组加用中药安慰剂治疗,疗程均为90 d。比较治疗前后两组患者夜间最低血氧饱和度(SpO_(2))、呼吸暂停指数(AHI)、OSAHS疗效判定、中医证候疗效评定、中医症状积分的变化。结果:观察组脱落5例、对照组脱落8例,实际完成观察组43例,对照组40例。与治疗前比较,观察组夜间最低SpO_(2)、AHI均显著改善(P<0.01),且显著优于对照组(P<0.01);OSAHS疗效观察组优于对照组(χ^(2)=7.085,P<0.05);中医证候疗效,观察组总有效率81.40%(35/43),对照组总有效率15.00%(6/40),观察组明显高于对照组(χ^(2)=36.78,P<0.01);中医症状积分二组均较治疗前改善,在打鼾、憋醒、嗜睡、咳嗽4项主证上疗效相当,但在头昏头痛、胸闷胸痛、喘息、口干口渴等10项细节上观察组优于对照组(P<0.05)。结论:固本祛瘀解毒方联合常规西医治疗COPD合并OSAHS夜间低氧血症(肺脾肾虚、瘀毒交阻证),可改善患者最低SPO_(2)、提升OSAHS控制水平、提高生活质量、改善临床症状。 展开更多
关键词 慢性阻塞性肺疾病 阻塞性睡眠呼吸暂停低通气综合征 低氧血症 固本祛瘀解毒方 随机双盲 临床观察
原文传递
益气养阴祛瘀汤治疗干燥综合征对患者腮腺核素动态显像指标、免疫功能的影响研究
16
作者 徐杨杨 谢海 刘元奎 《中华中医药学刊》 北大核心 2025年第6期130-133,共4页
目的研究益气养阴祛瘀汤治疗干燥综合征对患者腮腺核素动态显像指标、免疫功能的影响。方法选取2022年1月—2023年1月医院治疗的干燥综合征患者84例,根据随机数表法随机均分为两组,观察组、对照组各42例。对照组患者采用常规西药治疗,... 目的研究益气养阴祛瘀汤治疗干燥综合征对患者腮腺核素动态显像指标、免疫功能的影响。方法选取2022年1月—2023年1月医院治疗的干燥综合征患者84例,根据随机数表法随机均分为两组,观察组、对照组各42例。对照组患者采用常规西药治疗,观察组在对照组基础上采用益气养阴祛瘀汤治疗,两组用药疗程3个月。比较两组的中医症状量化评分,疾病活动度改变[干燥综合征疾病活动指数(European League Against Rheumatism SS disease activity index,ESSDAI)和EULAR干燥综合征患者报告指数(EULAR SS Patient Reported Index,ESSPRI)],腮腺核素动态显像指标[摄取分数(intake fraction,IF)、排泌分数(excretion fraction,EF)],免疫功能指标[血沉(erythrocyte sedimentation Rate,ESR)、C反应蛋白(C-reactive protein,CRP)、免疫球蛋白G(immunoglobulin G,IgG)、抗干燥综合征抗原A(Sj9gren's syndrome type A,SSA)抗体、抗干燥综合征抗原B(Sj9gren's syndrome type B,SSB)抗体]及不良反应发生情况。结果治疗前,两组患者的各项观察指标差异无统计学意义(P>0.05)。治疗后,观察组中医症状舌红津少、无苔/少苔/花剥、口干欲饮、眼干少泪评分均显著低于对照组[(1.72±0.53)(1.96±0.70)(2.03±0.91)(1.70±0.84)分vs(1.98±0.61)(2.36±0.59)(2.89±0.72)(2.13±0.77)分](P<0.05),观察组ESSDAI、EULAR评分均显著高于对照组[(5.92±1.60)(4.36±1.02)分vs(6.87±1.54)(5.39±0.96)分](P<0.05),腮腺核素动态显像IF、EF均显著高于对照组[(1.87±0.26)%、(21.07±4.20)%vs(1.74±0.19)%、(17.96±3.75)%],免疫功能指标ESR、IgG、抗SSA抗体阳性率、抗SSB抗体阳性率均显著优于对照组[(19.83±1.84)mm/h、(6.90±1.37)g/L、(41.28±5.69)%、(28.91±4.03)%vs(21.05±1.69)mm/h、(8.81±1.19)g/L、(53.47±5.18)%、(36.28±3.71)%](P<0.05)。观察组不良反应发生率7.14%与对照组11.90%比较,差异无统计学意义(P>0.05)。结论益气养阴祛瘀汤治疗干燥综合征效果满意,其能够更有效地缓解患者症状,改善机体免疫功能和腮腺核素动态显像指标,且用药安全性可靠,具有应用价值。 展开更多
关键词 干燥综合征 益气养阴祛瘀汤 硫酸羟氯喹片 腮腺核素动态显像 免疫功能
原文传递
子午流注针法联合补气祛瘀汤治疗卒中后环咽肌失弛型吞咽障碍临床研究
17
作者 吴梦婷 刘薇 《中华中医药学刊》 北大核心 2025年第5期214-217,共4页
目的探究子午流注针法联合补气祛瘀汤在卒中后环咽肌失弛型吞咽障碍治疗中的临床作用。方法收集卒中后环咽肌失弛型吞咽障碍患者60例,随机分为两组,试验组和对照组各30例。两组接受基础疗法,对照组予以补气祛瘀汤,试验组在对照组的基础... 目的探究子午流注针法联合补气祛瘀汤在卒中后环咽肌失弛型吞咽障碍治疗中的临床作用。方法收集卒中后环咽肌失弛型吞咽障碍患者60例,随机分为两组,试验组和对照组各30例。两组接受基础疗法,对照组予以补气祛瘀汤,试验组在对照组的基础上予以子午流注针法。对比两组颏下肌群表面肌电变化、洼田俊夫饮水试验(water swallow test,WST)、标准吞咽功能评估量表(standardized swallowing assessment,SSA)、吞咽障碍特异性生活质量量表(swallow quality-of-life questionnaire,SWAL-QOL)、吞咽X线荧光透视造影检查(videofluoroscopic swallowing study,VFSS)、临床疗效及并发症总发生率。结果治疗后两组下颏下肌群肌电均方根值(root mean square,RMS)水平降低(P<0.05);与对照组相比,试验组下颏下肌群RMS水平较低(P<0.05)。治疗后两组患者WST检查情况降低,且试验组WST检查低于对照组(P<0.05)。治疗后,两组SSA评分降低,SWAL-QOL评分、VFSS评分升高,且试验组SSA评分更低,SWAL-QOL、VFSS评分更高(P<0.05)。疗后试验组临床总有效率高于对照组,发生率低于对照组(P<0.05)。结论给予卒中后环咽肌失弛型吞咽障碍患者补气祛瘀汤联合子午流注针法的治疗措施,疗效佳,具有改善吞咽功能的优势,安全性高。 展开更多
关键词 补气祛瘀汤 子午流注针法 卒中后环咽肌失弛型吞咽障碍
原文传递
健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖的效果
18
作者 金斌斌 管子函 +2 位作者 戴盛锋 谢帆 张特 《江苏医药》 2025年第6期607-610,615,共5页
目的观察健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖的临床效果。方法72例单纯性肥胖患者随机分为研究组和对照组,每组36例。对照组接受常规治疗联合间歇性禁食疗法;研究组在对照组基础上加用健脾益肾化痰祛瘀方治疗,连续治疗... 目的观察健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖的临床效果。方法72例单纯性肥胖患者随机分为研究组和对照组,每组36例。对照组接受常规治疗联合间歇性禁食疗法;研究组在对照组基础上加用健脾益肾化痰祛瘀方治疗,连续治疗3个月。比较两组患者糖脂代谢指标和体质指标的变化。结果治疗前两组糖脂代谢指标比较均无统计学差异(P>0.05)。治疗后,两组FBG、餐后2-h血糖、HbA1c、HOMA-IR、TG、TC和LDL-C水平均较治疗前降低,HDL-C水平较治疗前升高(P<0.01),且研究组变化更为明显(P<0.01)。治疗后,研究组体重、腰围、臀围及BMI下降幅度均大于对照组(P<0.05),腰臀比小于对照组(P<0.05)。结论健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖效果良好,可加快减重速度,调控糖脂代谢。 展开更多
关键词 单纯性肥胖 健脾益肾化痰祛瘀方 间歇性禁食疗法 糖脂代谢
原文传递
基于能量代谢重编程探讨“去宛陈莝”法治疗糖尿病肾病的机理 被引量:1
19
作者 金鑫艳 于珊珊 +3 位作者 徐媛颖 沙雯君 鲁郡 雷涛 《辽宁中医杂志》 北大核心 2025年第12期8-11,共4页
糖尿病肾病的发病机制是多因素的,越来越多的证据表明代谢异常引发的各种细胞应激反应加速糖尿病肾病的发展进程。能量代谢重编程以能量流向紊乱、代谢过程转变、系统功能障碍为特点,贯穿于糖尿病肾病的发生发展过程,其引发的氧化应激... 糖尿病肾病的发病机制是多因素的,越来越多的证据表明代谢异常引发的各种细胞应激反应加速糖尿病肾病的发展进程。能量代谢重编程以能量流向紊乱、代谢过程转变、系统功能障碍为特点,贯穿于糖尿病肾病的发生发展过程,其引发的氧化应激、脂质积累和葡萄糖代谢终产物增多等与中医理论糖尿病肾病之脏腑气化失司,浊瘀内生的病机本质趋同且表征相仿。对于此病的治疗当以“通”为用,故以《黄帝内经》所提出的“去宛陈莝”法作为治疗原则,袪浊邪,助气化,畅气机,推陈致新,使稳态恢复,神机气立,机体各个环节得以正常发挥其功能,以拮抗糖尿病肾病的进展。 展开更多
关键词 能量代谢重编程 气化 去宛陈莝 糖尿病肾病
原文传递
阿司匹林联合活血祛瘀方治疗下肢动脉硬化闭塞症的临床评价 被引量:1
20
作者 尹凌峰 曹烨民 +2 位作者 徐磊 倪皓轩 王御震 《中国药学杂志》 北大核心 2025年第5期539-546,共8页
目的 探讨阿司匹林联合活血祛瘀方治疗下肢动脉硬化闭塞症(ASO)的临床疗效。方法 选择本院收治的下肢ASO患者136例作为研究对象,年龄范围为49~87岁,平均年龄(65.00±6.54)岁。根据不同治疗方法分为2组,常规阿司匹林治疗68例纳入对照... 目的 探讨阿司匹林联合活血祛瘀方治疗下肢动脉硬化闭塞症(ASO)的临床疗效。方法 选择本院收治的下肢ASO患者136例作为研究对象,年龄范围为49~87岁,平均年龄(65.00±6.54)岁。根据不同治疗方法分为2组,常规阿司匹林治疗68例纳入对照组,活血祛瘀方联合阿司匹林治疗68例纳入研究组。比较两组患者治疗前后血小板功能、血流动力学指标、血脂指标、动脉硬化指标、健康状况(SF-36)及临床疗效。采用广义估计方程(GEE)模型分析下肢ASO临床疗效的影响因素以及踝肱指数(ankle-brachial index, ABI)在不同时点、不同组别和不同分期的交互效应。结果 2组患者接受治疗6周后各项血小板功能、血流动力学指标、血脂指标及动脉硬化指标与治疗前相比均具有显著差异(P<0.05),研究组患者血小板聚集率(platelet aggregation rate, PAR)、D二聚体(D-dimer, D-D)、纤维蛋白原(fibrinogen, FIB)、全血高切黏度(high whole blood viscosity, HWBV)、全血低切黏度(low whole blood viscosity, LWBV)、红细胞沉降率(erythrocyte sedimentation rate, ESR)、总胆固醇(total cholesterol, TC)、三酰甘油(triacylglycerol, TG)及低密度脂蛋白胆固醇(low density lipoprotein cholesterol, LDL-C)水平均显著低于对照组(P<0.05),而患者出血时间(bleeding time, BT)、高密度脂蛋白(high density lipoprotein cholesterol, HDL-C)、ABI、趾肱指数(toe-brachial index, TBI)、跛行距离、健康状况评分及临床疗效均显著高于对照组(P<0.05);GEE模型分析结果显示治疗方法、治疗时间及Fontaine分期均显著影响下肢ASO的临床疗效(P<0.05);交互效应分析中治疗2周、4周,研究组和对照组中Ⅲ期、Ⅳ期ASO患者ABI值差异显著(P<0.05),治疗6周时,不同治疗方式对Ⅱ期、Ⅲ期、Ⅳ期ASO患者ABI值的影响具有统计学意义(P<0.05)。结论 阿司匹林联合活血祛瘀方治疗下肢ASO在血小板功能、血流动力学、血脂及动脉硬化等指标的改善方面优于单独使用阿司匹林,且治疗6周后联合用药的研究组的治疗总有效率和健康状况SF-36评分显著高于对照组;治疗方法、治疗时间及Fontaine分期均显著影响下肢ASO的治疗效果。 展开更多
关键词 下肢动脉硬化闭塞症 活血祛瘀方 阿司匹林 临床疗效
原文传递
上一页 1 2 46 下一页 到第
使用帮助 返回顶部